Tenofovir DF 300 mg + Emtricitabine 200 mg + Atazanavir 300 mg + Ritonavir 100 mg
This fixed-dose antiretroviral combination is used in the treatment of HIV-1 infection. In accordance with WHO and NACO guidelines, the regimen combines nucleos(t)ide reverse transcriptase inhibitors with a boosted protease inhibitor to effectively suppress viral replication as part of combination antiretroviral therapy (ART).
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Emtricitabine)
Protease Inhibitor with Pharmacokinetic Booster (Atazanavir + Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
To be administered once daily or as prescribed by a healthcare professional, in line with recommended ART regimens.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
10 Kit
Tenofovir DF 300 mg + Emtricitabine 200 mg + Atazanavir 300 mg + Ritonavir 100 mg
This fixed-dose antiretroviral combination is used in the treatment of HIV-1 infection. In accordance with WHO and NACO guidelines, the regimen combines nucleos(t)ide reverse transcriptase inhibitors with a boosted protease inhibitor to effectively suppress viral replication as part of combination antiretroviral therapy (ART).
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Emtricitabine)
Protease Inhibitor with Pharmacokinetic Booster (Atazanavir + Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
To be administered once daily or as prescribed by a healthcare professional, in line with recommended ART regimens.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
10 Kit
Tenofovir DF 300 mg + Emtricitabine 200 mg + Atazanavir 300 mg + Ritonavir 100 mg
This fixed-dose antiretroviral combination is used in the treatment of HIV-1 infection. In accordance with WHO and NACO guidelines, the regimen combines nucleos(t)ide reverse transcriptase inhibitors with a boosted protease inhibitor to effectively suppress viral replication as part of combination antiretroviral therapy (ART).
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Emtricitabine)
Protease Inhibitor with Pharmacokinetic Booster (Atazanavir + Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
To be administered once daily or as prescribed by a healthcare professional, in line with recommended ART regimens.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
10 Kit